| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An interaction between the interleukin-6 -174G<C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes
|
Stephens, Jeffrey W
|
|
2004
|
3 |
1 |
|
article
|
| 2 |
Arterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeys
|
Edwards, Iris J
|
|
2004
|
3 |
1 |
|
article
|
| 3 |
Cardiovascular adaptations to exercise training in postmenopausal women with type 2 diabetes mellitus
|
McGavock, Jonathan
|
|
2004
|
3 |
1 |
|
article
|
| 4 |
Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)
|
Aguilar-Salinas, Carlos A
|
|
2004
|
3 |
1 |
|
article
|
| 5 |
Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient
|
Woods, Philippe
|
|
2004
|
3 |
1 |
|
article
|
| 6 |
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
|
Pliquett, RU
|
|
2004
|
3 |
1 |
|
article
|
| 7 |
Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes
|
Sampson, Mike
|
|
2004
|
3 |
1 |
|
article
|
| 8 |
The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]
|
,
|
|
2004
|
3 |
1 |
|
article
|
| 9 |
Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation
|
Hayden, Melvin R
|
|
2004
|
3 |
1 |
|
article
|
| 10 |
Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
|
Tenenbaum, Alexander
|
|
2004
|
3 |
1 |
|
article
|
Journal description